Literature DB >> 20602103

The role of annexins I, II and IV in tumor development, progression and metastasis of human penile squamous cell carcinomas.

C Protzel1, M Richter, M Poetsch, C Kakies, U Zimmermann, C Woenckhaus, K J Klebingat, O W Hakenberg, J Giebel.   

Abstract

PURPOSE: The outcome of patients with penile squamous cell carcinomas (PSCC) largely depends on occurrence of metastasis. Therefore, prognostic markers indicating the risk for tumor cell spreading would be useful. Since Annexins are potential prognostic markers in a variety of tumors, we immunohistochemically examined the expression of Annexins I, II and IV (ANX AI, ANX AII and ANX AIV) in PSCC.
METHODS: Samples originated from 29 patients subjected to surgical resection of invasive PSCC. Immunohistochemistry was done on paraffin-embedded sections using monoclonal antibodies against ANX AI, ANX AII and ANX AIV. Expression of ANXs was compared with clinical data.
RESULTS: ANX AI expression was found in conventional PSCC and was absent in basaloid and sarcomatoid subtypes. High ANX AI score was significantly associated with higher T stages (P = 0.006). Strong expression in the invasion front of carcinomas was significantly associated with the occurrence of lymph node metastasis (P = 0.001). ANX AIV expression was weak in conventional PSCC, while it was strong in basaloid and sarcomatoid subtypes. Strong expression of Annnexin IV in the invasion front also showed a significant association with metastasis (P = 0.019).
CONCLUSION: Expression of ANXs was different in histologic subtypes of penile carcinomas. Strong expression of ANX AI and ANX AIV in the invasion front seems to indicate a higher risk of lymph node metastasis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20602103     DOI: 10.1007/s00345-010-0575-x

Source DB:  PubMed          Journal:  World J Urol        ISSN: 0724-4983            Impact factor:   4.226


  23 in total

1.  Mitogenesis, cell migration, and loss of focal adhesions induced by tenascin-C interacting with its cell surface receptor, annexin II.

Authors:  C Y Chung; J E Murphy-Ullrich; H P Erickson
Journal:  Mol Biol Cell       Date:  1996-06       Impact factor: 4.138

2.  Tenascin C and annexin II expression in the process of pancreatic carcinogenesis.

Authors:  I Esposito; R Penzel; M Chaib-Harrireche; U Barcena; F Bergmann; S Riedl; H Kayed; N Giese; J Kleeff; H Friess; P Schirmacher
Journal:  J Pathol       Date:  2006-04       Impact factor: 7.996

3.  Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors.

Authors:  Brian A Babbin; Winston Y Lee; Charles A Parkos; L Matthew Winfree; Adil Akyildiz; Mauro Perretti; Asma Nusrat
Journal:  J Biol Chem       Date:  2006-05-04       Impact factor: 5.157

4.  Expression of annexin AI in conventional renal cell carcinoma (CRCC) correlates with tumour stage, Fuhrman grade, amount of eosinophilic cells and clinical outcome.

Authors:  U Zimmermann; C Woenckhaus; S Teller; S Venz; M Langheinrich; C Protzel; S Maile; H Junker; J Giebel
Journal:  Histol Histopathol       Date:  2007-05       Impact factor: 2.303

5.  Localization of annexins I, II, IV and VII in whole prostate sections from radical prostatectomy patients.

Authors:  U Lehnigk; U Zimmermann; C Woenckhaus; J Giebel
Journal:  Histol Histopathol       Date:  2005-07       Impact factor: 2.303

6.  Expression of annexin II in conventional renal cell carcinoma is correlated with Fuhrman grade and clinical outcome.

Authors:  U Zimmermann; C Woenckhaus; S Pietschmann; H Junker; S Maile; K Schultz; C Protzel; J Giebel
Journal:  Virchows Arch       Date:  2004-08-26       Impact factor: 4.064

7.  Increased expression and altered location of annexin IV in renal clear cell carcinoma: a possible role in tumour dissemination.

Authors:  Uwe Zimmermann; Stefan Balabanov; Jürgen Giebel; Steffen Teller; Heike Junker; Dieter Schmoll; Chris Protzel; Christian Scharf; Britta Kleist; Reinhard Walther
Journal:  Cancer Lett       Date:  2004-06-08       Impact factor: 8.679

8.  Down-regulation of the metastasis suppressor protein KAI1/CD82 correlates with occurrence of metastasis, prognosis and presence of HPV DNA in human penile squamous cell carcinoma.

Authors:  C Protzel; C Kakies; B Kleist; M Poetsch; J Giebel
Journal:  Virchows Arch       Date:  2008-02-28       Impact factor: 4.064

9.  Role of cancer microenvironment in metastasis: focus on colon cancer.

Authors:  Stéphanie Gout; Jacques Huot
Journal:  Cancer Microenviron       Date:  2008-03-14

10.  Annexin II represents metastatic potential in clear-cell renal cell carcinoma.

Authors:  Y Ohno; M Izumi; T Kawamura; T Nishimura; K Mukai; M Tachibana
Journal:  Br J Cancer       Date:  2009-06-09       Impact factor: 7.640

View more
  5 in total

Review 1.  Penile cancer: current therapy and future directions.

Authors:  G Sonpavde; L C Pagliaro; C Buonerba; T B Dorff; R J Lee; G Di Lorenzo
Journal:  Ann Oncol       Date:  2013-01-04       Impact factor: 32.976

2.  Proteomic identification of tumor biomarkers associated with primary gallbladder cancer.

Authors:  Hai-Lin Huang; Hou-Shan Yao; Yi Wang; Wei-Jun Wang; Zhi-Qian Hu; Kai-Zhou Jin
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

Review 3.  Molecular research in penile cancer-lessons learned from the past and bright horizons of the future?

Authors:  Chris Protzel; Philippe E Spiess
Journal:  Int J Mol Sci       Date:  2013-09-26       Impact factor: 5.923

4.  Annexin A3 as a Prognostic Biomarker for Breast Cancer: A Retrospective Study.

Authors:  Tao Zhou; Yong Li; Li Yang; Tiantian Tang; Lina Zhang; Jiajie Shi
Journal:  Biomed Res Int       Date:  2017-04-13       Impact factor: 3.411

5.  Overexpression of ANXA1 in penile carcinomas positive for high-risk HPVs.

Authors:  Marilia Freitas Calmon; Mânlio Tasso de Oliveira Mota; Érica Babeto; Natália Maria Candido; Ana Paula Girol; Carlos Fabian Mendiburu; Jane Lopes Bonilha; Rodrigo Vellasco Duarte Silvestre; Bruno Miziara Rosa; Jorge Alberto Thomé; Gustavo Hernandez Américo Medeiros; Fernando Augusto Soares; Gustavo Cardoso Guimarães; José Germano Ferraz de Arruda; Sonia Maria Oliani; Luisa Lina Villa; José Vassallo; Paula Rahal
Journal:  PLoS One       Date:  2013-01-14       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.